Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

ZOLADEX™ implant 10.8mg, syringe applicators 1pc

🔥 9 items sold in last 3 hours
9 people are viewing this product
  • Zoladex™ Implant 10.8Mg, Syringe Applicators 1Pc Buy Online 3
  • Zoladex™ Implant 10.8Mg, Syringe Applicators 1Pc Buy Online 5
Brand:
Active Ingredient:

Manufacturer:

$854.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ZOLADEX™ implant 3.6mg, syringe applicators 1pc

$253.00
Add to cart

Analogs of ZOLADEX™

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

OLEOS SUPERCHISTOTEL™ solution 5ml, 1pc

$11.00
Add to cart

ABAKTAL™ tablets 400mg, 10pcs

$42.00
Add to cart

ABISIL™ oily solution 20% (15ml), 1pc

$54.00
Add to cart

Table of Contents

ZOLADEX™ 10.8mg Implant Buy Online

Zoladex 10.8mg Implant: A Comprehensive Overview

Managing hormone-related conditions requires precise and effective treatment options. Zoladex 10.8mg, a slow-release implant, offers a unique approach to hormonal therapy, providing consistent medication delivery over an extended period. This comprehensive overview explores its applications, mechanism, and considerations.

Zoladex 10.8mg is a medicated implant containing goserelin acetate, a synthetic hormone. Its controlled release mechanism minimizes the need for frequent injections, offering patients a more convenient treatment regimen. The implant is designed to gradually release the medication over a period of time, maintaining therapeutic levels in the body.

This innovative approach makes Zoladex 10.8mg a valuable tool for managing a variety of conditions. Its effectiveness and convenience have made it a significant advancement in hormone therapy. The precise dosage and extended release time contribute to its efficacy in various medical applications.

What is Zoladex 10.8mg?

Zoladex 10.8mg is a hormone therapy medication administered via a subcutaneous implant. This means a small, biodegradable pellet containing 10.8mg of goserelin acetate is injected under the skin, typically in the abdomen. The implant gradually releases the medication over a period of time, providing sustained therapeutic levels. This controlled release mechanism distinguishes it from other hormonal therapies requiring more frequent administrations.

Goserelin acetate itself is a synthetic gonadotropin-releasing hormone (GnRH) agonist. While initially stimulating hormone release, its prolonged presence ultimately suppresses the production of gonadotropins (luteinizing hormone and follicle-stimulating hormone) by the pituitary gland. This suppression leads to a significant reduction in the production of sex hormones such as testosterone in men and estrogen in women. The resulting hormonal suppression is the basis of Zoladex’s therapeutic action in various clinical applications.

The 10.8mg formulation is designed for longer-acting efficacy compared to lower-dose options. The extended release profile contributes to improved patient compliance and reduced treatment burden, requiring less frequent medical intervention. The biodegradable nature of the implant ensures complete absorption by the body, eliminating the need for removal after the medication is depleted. It is important to note that Zoladex 10.8mg is a prescription medication and should only be administered under the guidance of a qualified healthcare professional.

Medical Applications of Zoladex 10.8mg

Zoladex 10.8mg finds application in a range of conditions where hormonal suppression is a key therapeutic strategy. Its efficacy stems from its ability to significantly reduce the levels of circulating sex hormones, impacting various physiological processes. The extended release formulation ensures consistent therapeutic levels, contributing to improved treatment outcomes.

In men, Zoladex 10.8mg is primarily used in the management of advanced prostate cancer. By suppressing testosterone production, it can help slow the growth of hormone-sensitive prostate tumors, alleviating symptoms and potentially extending survival. This application leverages the drug’s ability to effectively reduce androgen levels, a crucial factor in prostate cancer progression.

In women, Zoladex 10.8mg has applications in the treatment of endometriosis and uterine fibroids. By reducing estrogen levels, it can lessen the symptoms associated with these conditions, such as painful periods and heavy bleeding. Furthermore, it is sometimes used in the preparation for certain gynecological surgeries, creating a more favorable environment for the procedure. The precise role and efficacy of Zoladex in these applications may vary depending on individual patient characteristics and the specific clinical context. Always consult a medical professional for appropriate diagnosis and treatment.

Beyond these common uses, Zoladex may also be employed in other situations where controlled hormonal suppression is beneficial. These may include certain types of precocious puberty and breast cancer. The specific application will depend on individual patient factors and the clinical judgment of the healthcare provider. Detailed information regarding specific treatment protocols should be obtained directly from a medical professional.

Administration and Dosage

Zoladex 10.8mg is administered as a single subcutaneous injection. A healthcare professional trained in its administration will inject the implant using a specialized applicator, typically into the anterior abdominal wall. The precise injection site should be determined by the physician, considering factors such as patient comfort and potential complications. The procedure itself is generally well-tolerated, and most patients experience minimal discomfort.

The standard dosage is a single 10.8mg implant, which is designed to provide sustained drug release over a period of approximately 12 weeks. This extended release profile minimizes the need for frequent injections, enhancing convenience for patients. The duration of therapy will depend on the specific medical condition being treated and the individual patient’s response to the medication. Regular monitoring by a physician is crucial to assess treatment efficacy and adjust the treatment plan as needed.

It is crucial to emphasize that Zoladex 10.8mg should only be administered by a qualified healthcare professional. Improper administration could lead to complications, highlighting the importance of adhering to established protocols. The use of the appropriate applicator and adherence to sterile techniques are vital to ensure patient safety and optimal treatment outcomes. Patients should always discuss any concerns or questions regarding administration with their physician or nurse.

The frequency of administration is typically every 12 weeks, but this can vary depending on the condition being treated and the patient’s response. The physician will determine the appropriate dosing schedule and duration of therapy based on individual patient needs and ongoing assessment of the treatment’s effectiveness. Consistent follow-up appointments are essential for monitoring progress and making any necessary adjustments to the treatment plan.

Mechanism of Action

Zoladex 10.8mg exerts its therapeutic effects through a sophisticated mechanism involving the hypothalamic-pituitary-gonadal (HPG) axis. The active ingredient, goserelin acetate, is a synthetic analog of gonadotropin-releasing hormone (GnRH). Initially, goserelin mimics GnRH, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. However, this initial stimulation is short-lived.

With continued exposure to goserelin, a phenomenon known as down-regulation occurs. The prolonged stimulation of the pituitary gland leads to a depletion of GnRH receptors, resulting in a subsequent suppression of LH and FSH release. This suppression is crucial because LH and FSH are essential for the production of sex hormones—testosterone in men and estrogen in women. The resulting decline in sex hormone levels is the primary mechanism by which Zoladex achieves its therapeutic effects.

The sustained release of goserelin from the implant ensures continuous suppression of the HPG axis, maintaining therapeutic levels of hormonal suppression for an extended period (approximately 12 weeks for the 10.8mg formulation). This prolonged suppression is critical for the management of conditions such as prostate cancer and endometriosis, where hormonal influences play a significant role in disease progression. The specific impact on various physiological processes depends on the condition being treated and the individual patient’s response to the medication.

It’s important to understand that while Zoladex effectively reduces sex hormone levels, it doesn’t directly target the underlying disease process. Instead, it modifies the hormonal environment, creating conditions less favorable for the growth and progression of hormone-sensitive cancers or the symptoms of conditions like endometriosis. The effectiveness of Zoladex relies on the sensitivity of the target condition or tumor to hormonal changes induced by the medication. This sensitivity varies among individuals, influencing treatment outcomes.

Pros of Zoladex 10.8mg

Advantages

Zoladex 10.8mg offers several key advantages compared to other hormonal therapies. Its extended-release formulation significantly improves patient convenience, reducing the frequency of doctor visits and injections. This convenient administration schedule enhances patient compliance, which is crucial for long-term treatment success. The reduced burden of frequent injections contributes to improved patient satisfaction and overall quality of life.

The sustained release of goserelin provides consistent therapeutic levels of hormonal suppression, leading to more predictable and effective treatment outcomes. This consistent drug delivery helps minimize fluctuations in hormone levels, which can be associated with adverse effects or reduced treatment efficacy in other hormonal therapies. The predictable and controlled release of the medication is a significant advantage for managing chronic conditions requiring long-term hormonal suppression.

Compared to other treatments, Zoladex’s single-injection approach minimizes the risk of repeated needle punctures, reducing discomfort and potential complications at the injection site. This is particularly beneficial for patients who experience significant anxiety or discomfort related to injections. The reduced number of injections contributes to improved patient experience and a less stressful therapeutic regimen. The single injection also simplifies the overall treatment process.

Finally, the biodegradable nature of the implant eliminates the need for surgical removal, further enhancing patient convenience and minimizing potential risks associated with a secondary procedure. The complete absorption of the implant by the body ensures a non-invasive and safe method of drug delivery. This self-dissolving feature contributes to a streamlined treatment process and avoids the complications associated with foreign body reactions or the need for additional procedures.

Advantages

The convenience of Zoladex’s extended-release mechanism is a significant advantage. Requiring fewer injections compared to other hormonal therapies translates to less frequent clinic visits and reduced disruption to daily life. This aspect improves patient compliance, a crucial factor influencing treatment success, particularly in long-term management of chronic conditions. The improved patient experience contributes to better overall adherence to the prescribed regimen.

Furthermore, the consistent hormone suppression provided by Zoladex leads to more predictable therapeutic effects. This controlled release minimizes the hormonal fluctuations that can occur with other medications, reducing the likelihood of unpredictable side effects or treatment inefficacy. The stable hormonal environment helps optimize treatment outcomes and minimizes potential adverse events associated with hormonal imbalances. Predictability in treatment response is highly valued in medical practice.

Another key advantage is the minimally invasive administration. The single subcutaneous injection is generally well-tolerated, causing minimal discomfort compared to more invasive procedures or multiple injections. This simple administration method contributes to improved patient comfort and reduces the anxiety often associated with repeated needle injections. The reduced invasiveness enhances the overall patient experience and increases the acceptability of treatment.

Finally, the biodegradable nature of the implant is a considerable benefit. The implant is completely absorbed by the body, eliminating the need for a separate surgical procedure to remove it. This feature simplifies the treatment process, avoids potential complications associated with a secondary procedure, and ultimately improves patient convenience. The self-dissolving nature of the implant makes for a streamlined and less intrusive treatment experience.

Cons of Zoladex 10.8mg

Drawbacks

While Zoladex 10.8mg offers significant advantages, it’s essential to acknowledge potential drawbacks. A common side effect is the suppression of sex hormones, leading to symptoms like hot flashes, decreased libido, and changes in mood. These effects vary in severity among individuals and are often manageable with supportive care or additional medication. The intensity and duration of these symptoms are influenced by various factors including the individual’s sensitivity to hormonal changes and the underlying medical condition.

Another potential side effect is osteoporosis, due to the long-term suppression of estrogen and testosterone. This risk is particularly relevant in women and is often mitigated through lifestyle modifications, such as increased calcium and vitamin D intake, weight-bearing exercise, and in some cases, supplementary medications. Regular bone density monitoring may be necessary to assess risk and guide preventative strategies. The risk of osteoporosis increases with duration of treatment and individual susceptibility.

Some patients may experience injection site reactions, such as pain, swelling, or redness. These reactions are usually mild and transient, resolving spontaneously within a few days. However, more severe reactions are possible, though infrequent. Prompt reporting of any unusual symptoms at the injection site to the healthcare provider is crucial for appropriate management. Careful injection techniques and proper aseptic procedures help minimize the risk of these reactions.

Finally, it’s important to note that Zoladex is not a cure for the underlying condition. Instead, it manages symptoms and potentially slows disease progression. The long-term effectiveness of Zoladex can vary among individuals, and ongoing medical monitoring is crucial to assess treatment response and make necessary adjustments to the therapy or consider alternative treatment options. Treatment success depends on a variety of factors including the patient’s overall health, the severity of their condition, and their individual response to the medication.

Additional Information

Drawbacks

One significant drawback associated with Zoladex 10.8mg is the potential for hormone-related side effects. Because the medication suppresses sex hormone production, patients may experience symptoms such as hot flashes, night sweats, decreased libido, vaginal dryness, mood changes, and weight fluctuations. The severity of these side effects varies considerably between individuals, and their management often involves lifestyle adjustments and, in some cases, supplementary medications. The duration and intensity of these side effects are also highly variable.

The risk of osteoporosis is another important consideration, particularly in women and post-menopausal individuals. The long-term suppression of estrogen and testosterone can weaken bones, increasing the risk of fractures. Preventative measures, such as increased calcium and vitamin D intake, regular weight-bearing exercise, and possibly bone-strengthening medications, are often recommended to mitigate this risk. Regular bone density monitoring helps to track bone health and allows for early intervention if necessary.

While uncommon, injection site reactions can occur. These may range from mild discomfort and localized swelling to more severe reactions. Proper injection technique by trained healthcare professionals is crucial in minimizing this risk. Patients should report any unusual symptoms at the injection site to their healthcare provider for prompt assessment and management. Early intervention is key to preventing complications and ensuring optimal patient outcomes.

Finally, it is crucial to remember that Zoladex 10.8mg is a treatment, not a cure, for the underlying condition. Therefore, ongoing medical supervision and monitoring of the disease are necessary to evaluate treatment efficacy, adjust the treatment plan as needed, or explore alternative therapeutic approaches if the initial response is unsatisfactory. Regular follow-up appointments with the treating physician are essential for optimal management and to ensure the treatment continues to be effective.

  • Zoladex™ Implant 10.8Mg, Syringe Applicators 1Pc Buy Online 7
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Zoladex™ Implant 10.8Mg, Syringe Applicators 1Pc Buy Online 9
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Zoladex™ Implant 10.8Mg, Syringe Applicators 1Pc Buy Online 11
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “ZOLADEX™ implant 10.8mg, syringe applicators 1pc”

Your email address will not be published. Required fields are marked

Similar products

LORETA™ tablets 2.5mg, 30pcs

$85.00
Add to cart

LESTRODEX™ tablets 2.5mg, 30pcs

$134.00
Add to cart

LETROZOLE tablets 2.5mg, 30pcs

$519.00
Add to cart

XTANDI™ capsules 40mg, 112pcs

$11,062.00
Add to cart

CLADRIBINE concentrate for infusion solution 1mg/ml (10ml), vial 1pc

$299.00
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (15ml), vial 1pc

$80.00
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (45ml), vial 1pc

$158.00
Add to cart

CABOMETYX™ tablets 40mg, 30pcs

$25,072.00
Add to cart

IMBRUVICA™ capsules 140mg, 90pcs

$28,002.00
Add to cart

IMATINIB tablets 100mg, 30pcs

$163.00
Add to cart

ZENLISTIK™ tablets 150mg, 56pcs

$4,810.00
Add to cart

ZARSIO™ solution for IV and SC injection 48 million IU/0.5ml (0.5ml), syringes 5pcs

$1,273.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (16ml), vial 1pc

$898.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (8ml), vial 1pc

$689.00
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 440mg + solvent 20ml, vial 1pc

$1,945.00
Add to cart

HEMANGIOL™ oral solution 3.75mg/ml (120ml), vial 1pc

$1,143.00
Add to cart

BICALUTAMIDE tablets 150mg, 30pcs

$151.00
Add to cart

BIKANA™ tablets 50mg, 28pcs

$53.00
Add to cart

BARTIZAR™ lyophilisate for IV/SC injection 3.5mg, 1pc

$934.00
Add to cart

BAVENCIO™ concentrate for infusion solution 20mg/ml (10ml), vial 1pc

$3,690.00
Add to cart

ARFLEIDA™ concentrate for infusion solution 25mg/ml (4ml), 1 vial

$7,437.00
Add to cart

ANASTROZOLE tablets 1mg, 30pcs

$80.00
Add to cart

ANAZALES™ tablets 1mg, 28pcs

$73.00
Add to cart

AVASTIN™ concentrate for infusion solution 25mg/ml (400mg/16ml), vial 16ml 1pc

$2,272.00
Add to cart
Select your currency